Lenmid 10 mg Capsule contains lenalidomide, an immunomodulatory agent that treats multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. It enhances the immune system’s ability to fight cancer cells and inhibits tumor growth. For more detailed information, visit Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, and WHO.

Key Benefits & Uses

• Multiple Myeloma: Doctors prescribe Lenmid with dexamethasone for newly diagnosed patients and as maintenance therapy after stem cell transplants (Mayo Clinic).

• Myelodysplastic Syndromes (MDS): Lenmid reduces the need for blood transfusions in patients with a deletion of chromosome 5q (Drugs.com).

• Mantle Cell Lymphoma (MCL): Patients who fail previous treatments with bortezomib respond positively to Lenmid (Mayo Clinic) (WebMD).

How to Use

Patients take Lenmid 10 mg Capsule orally, typically once daily. Specifically, for multiple myeloma, they take it on days 1–21 of a 28-day cycle. Doctors may adjust the dosage based on blood counts and side effects. For guidance, see Drugs.com, Mayo Clinic, and PubMed.

Important Safety Information

• Pregnancy: Do not take Lenmid during pregnancy because it may harm the fetus (FDA) (WHO).

• Blood Counts: Doctors monitor blood counts regularly to detect neutropenia or thrombocytopenia (Drugs.com).

• Thromboembolism: Patients face an increased risk for blood clots; therefore, doctors may recommend anticoagulants (Mayo Clinic).

• Liver Function: Doctors recommend periodic liver function tests to prevent hepatotoxicity (Healthline) (PubMed).

Common Side Effects

Patients may experience:

• Gastrointestinal: Diarrhea, constipation, nausea (WebMD) (Healthline).

• Hematologic: Anemia, neutropenia, thrombocytopenia (PubMed) (Mayo Clinic).

• General: Fatigue, fever, rash (Drugs.com) (WHO).

Why Choose Lenmid 10 mg Capsule

Lenmid provides a targeted approach that improves patient outcomes in hematologic malignancies. Additionally, it reduces transfusion dependence in MDS and increases survival in multiple myeloma. Doctors rely on Lenmid for its proven therapeutic benefits (Mayo Clinic) (FDA) (Drugs.com).